tiprankstipranks
Silence Therapeutics to Transition to U.S. Issuer Status
PremiumCompany AnnouncementsSilence Therapeutics to Transition to U.S. Issuer Status
2M ago
Silence Therapeutics Advances Promising siRNA Therapy for PV
Premium
Company Announcements
Silence Therapeutics Advances Promising siRNA Therapy for PV
3M ago
Silence Therapeutics announces additional results from SANRECO study
Premium
The Fly
Silence Therapeutics announces additional results from SANRECO study
3M ago
Silence Therapeutics presents late-breaking Phase 2 zerlasiran data at AHA
PremiumThe FlySilence Therapeutics presents late-breaking Phase 2 zerlasiran data at AHA
3M ago
Silence Therapeutics: Rising Assets Amid Growing Losses
Premium
Company Announcements
Silence Therapeutics: Rising Assets Amid Growing Losses
3M ago
Silence Therapeutics Plc (SLN) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Silence Therapeutics Plc (SLN) Q3 Earnings Cheat Sheet
3M ago
Silence Therapeutics Reports Increased Losses
PremiumCompany AnnouncementsSilence Therapeutics Reports Increased Losses
6M ago
Seven new option listings and one option delisting on July 10th
Premium
The Fly
Seven new option listings and one option delisting on July 10th
8M ago
Silence Therapeutics price target raised to $55 from $42 at Chardan
Premium
The Fly
Silence Therapeutics price target raised to $55 from $42 at Chardan
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100